Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ · Healthcare
Xeris Biopharma Holdings, Inc. Net Income 2020–2025
Xeris Biopharma Holdings, Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Xeris Biopharma Holdings, Inc. net income for the quarter ending March 31, 2026 was 2.2 M, a 124.23% decrease year-over-year.
- Xeris Biopharma Holdings, Inc. net income for the twelve months ending March 31, 2026 was -8.3 M, a 86.61% decrease year-over-year.
- Xeris Biopharma Holdings, Inc. annual net income for 2025 was 554000, a 101.01% decrease from 2024.
- Xeris Biopharma Holdings, Inc. annual net income for 2024 was -54.8 M, a 11.92% decrease from 2023.
- Xeris Biopharma Holdings, Inc. annual net income for 2023 was -62.3 M, a 34.23% decrease from 2022.
- Xeris Biopharma Holdings, Inc. annual net income for 2022 was -94.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Xeris Biopharma Holdings, Inc. Net Income — FAQ
Xeris Biopharma Holdings, Inc. (XERS) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Xeris Biopharma Holdings, Inc.'s net income?
Xeris Biopharma Holdings, Inc. (XERS) reported net income of $554,000 for fiscal 2025.
Where can I see XERS's net income history?
The chart and table above show Xeris Biopharma Holdings, Inc.'s net income by year and by quarter, including the growth rate.